Intravenous Dexmedetomidine for Emergence Delirium in Pediatric Patient
Emergence Delirium, Dexmeditomidine
About this trial
This is an interventional prevention trial for Emergence Delirium focused on measuring emergence delirium, dexmeditomidine, pediatric patients
Eligibility Criteria
Inclusion Criteria: Patients aged between 2 and 12 years, scheduled to undergo general anesthesia for a surgery with an ASA score of 1 to 3 will be included in the study. Exclusion Criteria: Parents who refused enrollment or later requested removal for the study, those who are unable to give informed consent and patients with known allergy to dexmedetomidine, psychiatric disorders or use of psychiatric medications will not be included in the study
Sites / Locations
- Security Forces HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Dexmedetomidine group
Control group
These patients will receive 0.2 mcg/kg dexmedetomidine intravenously 30 minutes before end
These patients will receive normal saline intravenously 30 minutes before end